SCHEMBL4031191

SCHEMBL4031191

OCc1ccc2cc3c(cc2c1)CCO3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.38
CA2 P00918 2/20 0.38
CA3 P07451 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
CA5A P35218 1/20 0.38
PRKCI P41743 1/20 0.38
KCNH2 Q12809 1/20 0.37
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
OGA O60502 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRNB2 P17787 1/20 0.36
CHRM3 P20309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633962 0.81 CHRM2 (0.50) PRKCIKCNH2RAB9ANPC1POLB
SCHEMBL317341 0.81 PRKCI (0.51) PRKCIRAB9ANPC1POLBMEN1
SCHEMBL30922323 0.81 PRKCI (0.51) PRKCIRAB9ANPC1POLBMEN1
SCHEMBL8344049 0.78 MAOA (0.45) PRKCIRAB9ANPC1DYRK1AMAOA
SCHEMBL4027061 0.78 CYP3A4 (0.46) CA12CA2CA3CA4CA6
SCHEMBL1652999 0.75 DYRK1A (0.43) PRKCIKCNH2RAB9ANPC1MEN1
SCHEMBL14409815 0.75 CYP2A6 (0.46) PRKCIKCNH2RAB9ADYRK1AMAOB
SCHEMBL7569179 0.72 CYP2A6 (0.44) CA2CA5ARAB9A
SCHEMBL19048361 0.72 DYRK1A (0.54) PRKCIKCNH2RAB9ANPC1POLB
SCHEMBL13525455 0.72 CA2 (0.50) CA12CA2CA3CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed
EP-1222174-A1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE Takeda Chemical Industries, Ltd. (JP) 2002-07-17 EP disclosed
WO-2001030762-A1 IMIDAZOL-4-YLMETHANOLS USE AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-03 WO disclosed